medical research council - wipo · prof a walubo – uovs. dr m mhlakaza – centre for diabetes....
TRANSCRIPT
![Page 1: Medical Research Council - WIPO · Prof A Walubo – UOVS. Dr M Mhlakaza – Centre for Diabetes. Dr P Moodley - GP. Project Leaders and collaborators. Dr Y Seier – Primate Unit](https://reader034.vdocuments.us/reader034/viewer/2022042710/5f6a5c2009d50b07960c83c7/html5/thumbnails/1.jpg)
“Building a healthy nation through research”
Medical Research Council
Indigenous Knowledge Systems [Health] Lead Programme “Going back to our roots for Innovative health solutions
![Page 2: Medical Research Council - WIPO · Prof A Walubo – UOVS. Dr M Mhlakaza – Centre for Diabetes. Dr P Moodley - GP. Project Leaders and collaborators. Dr Y Seier – Primate Unit](https://reader034.vdocuments.us/reader034/viewer/2022042710/5f6a5c2009d50b07960c83c7/html5/thumbnails/2.jpg)
Access and Benefit Sharing: Case Studies and International Experience
Topic Three:
South African Medical Research Council Case Studies: Indigenous Knowledge Systems Lead Programme
FICCI INTERNATIONAL ROUNDTABLE ON TRADITIONAL KNOWLEDGE
FICCI, Federation House, Tansen Marg, New Delhi
13th November 2009, NEW DELHI INDIA
Dr Motlalepula Gilbert Matsabisa2
![Page 3: Medical Research Council - WIPO · Prof A Walubo – UOVS. Dr M Mhlakaza – Centre for Diabetes. Dr P Moodley - GP. Project Leaders and collaborators. Dr Y Seier – Primate Unit](https://reader034.vdocuments.us/reader034/viewer/2022042710/5f6a5c2009d50b07960c83c7/html5/thumbnails/3.jpg)
3
FORMAT of the PRESENTATION
• South African Medical Research Council
• Indigenous Knowledge Systems Lead Programme
• MRC IKS Research Translation - Access and Benefit-sharing
CASE STUDIES
• Case Study 1: Partnerships, Training and Knowledge Generation - (Non-monetary)
• Case Study 2: Antimalarial Discovery – Monetary Beneficiation Principles
• Case Study 3: Poverty Alleviation and Wealth Creation –(Monetary and Non-monetary)
Case Study 4: IKS Business Model for Commercial exploitation of IK IP (Industrialization of ATM n contribution to 2o economies)
![Page 4: Medical Research Council - WIPO · Prof A Walubo – UOVS. Dr M Mhlakaza – Centre for Diabetes. Dr P Moodley - GP. Project Leaders and collaborators. Dr Y Seier – Primate Unit](https://reader034.vdocuments.us/reader034/viewer/2022042710/5f6a5c2009d50b07960c83c7/html5/thumbnails/4.jpg)
4
To promote and advance indigenous knowledge systems through research and development by making it a valued health model in the global environment and to redress health traditions, which until now have
neglected health research priorities and issues.
To be a centre of excellence in traditional medicines research regionally and to be competitive globally
To give the South African traditional Medicines research an international perspective
Mission and Vision
![Page 5: Medical Research Council - WIPO · Prof A Walubo – UOVS. Dr M Mhlakaza – Centre for Diabetes. Dr P Moodley - GP. Project Leaders and collaborators. Dr Y Seier – Primate Unit](https://reader034.vdocuments.us/reader034/viewer/2022042710/5f6a5c2009d50b07960c83c7/html5/thumbnails/5.jpg)
IKS Core Research Activities
RESEARCH & DEVELOPMENT
KNOWLEDGE DEVELOPMENT and
MANAGEMENT
IKS BUSINESS DEVELOPMENT
COMMUNITY SOCIAL IMPACT
![Page 6: Medical Research Council - WIPO · Prof A Walubo – UOVS. Dr M Mhlakaza – Centre for Diabetes. Dr P Moodley - GP. Project Leaders and collaborators. Dr Y Seier – Primate Unit](https://reader034.vdocuments.us/reader034/viewer/2022042710/5f6a5c2009d50b07960c83c7/html5/thumbnails/6.jpg)
6
Our Laboratories
IK Holders / THPs
Medicinal Garden
Analytical & Discovery laboratories
Manufacturing
Resource Centre
![Page 7: Medical Research Council - WIPO · Prof A Walubo – UOVS. Dr M Mhlakaza – Centre for Diabetes. Dr P Moodley - GP. Project Leaders and collaborators. Dr Y Seier – Primate Unit](https://reader034.vdocuments.us/reader034/viewer/2022042710/5f6a5c2009d50b07960c83c7/html5/thumbnails/7.jpg)
7
African Traditional Medicines Research and its Development
Research makes no difference to economy, health and quality of life of the people unless such research is translated into:
GRRIPPPP: Getting Research Results Into :Policy (Influence)PracticePromotion andProducts
![Page 8: Medical Research Council - WIPO · Prof A Walubo – UOVS. Dr M Mhlakaza – Centre for Diabetes. Dr P Moodley - GP. Project Leaders and collaborators. Dr Y Seier – Primate Unit](https://reader034.vdocuments.us/reader034/viewer/2022042710/5f6a5c2009d50b07960c83c7/html5/thumbnails/8.jpg)
CASE STUDY 1: PARTNERSHIPS, TRAINING AND KNOWLEDGE GENERATION - (NON-MONETARY)
8
![Page 9: Medical Research Council - WIPO · Prof A Walubo – UOVS. Dr M Mhlakaza – Centre for Diabetes. Dr P Moodley - GP. Project Leaders and collaborators. Dr Y Seier – Primate Unit](https://reader034.vdocuments.us/reader034/viewer/2022042710/5f6a5c2009d50b07960c83c7/html5/thumbnails/9.jpg)
• Research and Discovery:Clinical ResearchResearch development & partnerships
Training Programs and Workshops GCP , IPR, Product development etc.
• Community Entrepreneurship and Business DevelopmentBusiness and Leadership development
• PoliticalIKS BillDTI patent amendment billNational Biodiversity Management ActMCC - ATM Expert Committee 9
![Page 10: Medical Research Council - WIPO · Prof A Walubo – UOVS. Dr M Mhlakaza – Centre for Diabetes. Dr P Moodley - GP. Project Leaders and collaborators. Dr Y Seier – Primate Unit](https://reader034.vdocuments.us/reader034/viewer/2022042710/5f6a5c2009d50b07960c83c7/html5/thumbnails/10.jpg)
CASE STUDY 2: ANTIMALARIAL DISCOVERY – MONETARY BENEFICIATION PRINCIPLES
10
![Page 11: Medical Research Council - WIPO · Prof A Walubo – UOVS. Dr M Mhlakaza – Centre for Diabetes. Dr P Moodley - GP. Project Leaders and collaborators. Dr Y Seier – Primate Unit](https://reader034.vdocuments.us/reader034/viewer/2022042710/5f6a5c2009d50b07960c83c7/html5/thumbnails/11.jpg)
National Trust Fund
Indigenous community and traditional healers
MRC
1/2
1/2
Local Trust Fund Specific for Traditional
Healers and their specific Community
Trustees
Traditional Healers & their Communities and
Research/ Funding Institution
Investigators
Re-invest into IKS Research
Individuals who supplied the Information &/or the Genetic material?
1/3
?
1/22/3
?
Benefit-sharing Model (Profits Generated)
Different community
Companies jointly with Private Partners
?
1/2
![Page 12: Medical Research Council - WIPO · Prof A Walubo – UOVS. Dr M Mhlakaza – Centre for Diabetes. Dr P Moodley - GP. Project Leaders and collaborators. Dr Y Seier – Primate Unit](https://reader034.vdocuments.us/reader034/viewer/2022042710/5f6a5c2009d50b07960c83c7/html5/thumbnails/12.jpg)
National Trust Fund
Indigenous communities and traditional healers
CONSORTIUM of Institutions
1/2
1/2
Local Trust Fund Specific Traditional
Healers and their specific Community
Trustees
Traditional Healers , their communities & Consortium
Investigators Re-invest into IKS development, education & research
X1
Individuals who supplied Information &/or the Genetic material
X2 X3 X4 XnX5
1/2
?
? ?
?
The Benefit-sharing Model Consortia
Trust Account / s
For
Different communities and
Traditional doctors
![Page 13: Medical Research Council - WIPO · Prof A Walubo – UOVS. Dr M Mhlakaza – Centre for Diabetes. Dr P Moodley - GP. Project Leaders and collaborators. Dr Y Seier – Primate Unit](https://reader034.vdocuments.us/reader034/viewer/2022042710/5f6a5c2009d50b07960c83c7/html5/thumbnails/13.jpg)
CASE STUDY 3: SOCIAL IMPACTS FOR POVERTY ALLEVIATION AND WEALTH CREATION
13
![Page 14: Medical Research Council - WIPO · Prof A Walubo – UOVS. Dr M Mhlakaza – Centre for Diabetes. Dr P Moodley - GP. Project Leaders and collaborators. Dr Y Seier – Primate Unit](https://reader034.vdocuments.us/reader034/viewer/2022042710/5f6a5c2009d50b07960c83c7/html5/thumbnails/14.jpg)
14
IKS and competitiveness
• The programme is based on the production, industrialization and commercial development of scientifically validated medicinal plants as sources of competitive advantages for entrepreneurial based community projects.
![Page 15: Medical Research Council - WIPO · Prof A Walubo – UOVS. Dr M Mhlakaza – Centre for Diabetes. Dr P Moodley - GP. Project Leaders and collaborators. Dr Y Seier – Primate Unit](https://reader034.vdocuments.us/reader034/viewer/2022042710/5f6a5c2009d50b07960c83c7/html5/thumbnails/15.jpg)
15
ATM Community Business Development - Theoretical model
Commercial viability
Technical viability
Entrepreneurial viability
Economicgrowth
environment(INDUSTRIAL
VIABILITY)
INSTITUTIONALSUPPORT
INSTITUTIONALSUPPORT
Local AuthoritiesScience InstitutionsPrivate Sector, VCs, BRICs, Government Depts.Science CouncilsInstitutions of Higher Learning
Different Components of Industrial ViabilityMarkets
Institutional viability
![Page 16: Medical Research Council - WIPO · Prof A Walubo – UOVS. Dr M Mhlakaza – Centre for Diabetes. Dr P Moodley - GP. Project Leaders and collaborators. Dr Y Seier – Primate Unit](https://reader034.vdocuments.us/reader034/viewer/2022042710/5f6a5c2009d50b07960c83c7/html5/thumbnails/16.jpg)
Breede Valley Municipality
Geographical Scope of the Projects
16
![Page 17: Medical Research Council - WIPO · Prof A Walubo – UOVS. Dr M Mhlakaza – Centre for Diabetes. Dr P Moodley - GP. Project Leaders and collaborators. Dr Y Seier – Primate Unit](https://reader034.vdocuments.us/reader034/viewer/2022042710/5f6a5c2009d50b07960c83c7/html5/thumbnails/17.jpg)
CASE 4 –
IKS BUSINESS DEVELOPMENT : COMMERCIALIZATION MODEL FOR SOCIAL IMPACTS FOR POVERTY ALLEVIATION AND
WEALTH CREATION
17
![Page 18: Medical Research Council - WIPO · Prof A Walubo – UOVS. Dr M Mhlakaza – Centre for Diabetes. Dr P Moodley - GP. Project Leaders and collaborators. Dr Y Seier – Primate Unit](https://reader034.vdocuments.us/reader034/viewer/2022042710/5f6a5c2009d50b07960c83c7/html5/thumbnails/18.jpg)
18
CO 2
CO 1 COMPANY = IKS Spin-out
MRC TRUST
JV COMPANY
NewCo 1/ Project 1
NewCo 2 / Project 2
NewCo 3 / Project 3
10% 40% 25% 25%
Raise capital, Create new companies, buy, acquire etc
Pay royalties, Support Research related to company activities, clinical trials, students Royalty payouts only on NET profit
Create new partnerships, Translate selected research into businesses
Proposed MRC IKS Commercializing Entity
![Page 19: Medical Research Council - WIPO · Prof A Walubo – UOVS. Dr M Mhlakaza – Centre for Diabetes. Dr P Moodley - GP. Project Leaders and collaborators. Dr Y Seier – Primate Unit](https://reader034.vdocuments.us/reader034/viewer/2022042710/5f6a5c2009d50b07960c83c7/html5/thumbnails/19.jpg)
Funding
Loans / Preference shares to be redeemed upon maturity or converted to equity upon listing of underlying companies
LoansPreference shares
Ordinary shares Donor Capital
MEDRES
Royalty to applicable sources
New MRC initiative from the proceeds of research
Company /Project 3
Company /Project 2
Company/ Project 1
100%
Business Partner/s
MRC(Research Arm)
JV companywith Business
Partner/s
Create new companies - buy,
acquire, etc
Creating Partnerships and turning selected
research into business
FundersBusiness Partner/sGovernment bodiesCorporateFinancial InstitutionsDonors
PHEDISANANG
100%
![Page 20: Medical Research Council - WIPO · Prof A Walubo – UOVS. Dr M Mhlakaza – Centre for Diabetes. Dr P Moodley - GP. Project Leaders and collaborators. Dr Y Seier – Primate Unit](https://reader034.vdocuments.us/reader034/viewer/2022042710/5f6a5c2009d50b07960c83c7/html5/thumbnails/20.jpg)
Conclusion
20
• Establishing and securing markets for ATM
• Looking for serious industry partners for community commercial exploitation of ATM
• Technical skills exchange and development
• Community empowerment, involvement and wealth creation
• Horizontal & vertical integration development within the areas surrounding the medicinal plant projects
• Industrialization of African herbal medicinal plants (2o
economies)
• Local production of quality “Essential Traditional Medicines”
• Contribution to MDGs (MDG 4, 5 and 6)
![Page 21: Medical Research Council - WIPO · Prof A Walubo – UOVS. Dr M Mhlakaza – Centre for Diabetes. Dr P Moodley - GP. Project Leaders and collaborators. Dr Y Seier – Primate Unit](https://reader034.vdocuments.us/reader034/viewer/2022042710/5f6a5c2009d50b07960c83c7/html5/thumbnails/21.jpg)
21
IKS Staff Complement
• Staff:• Dr MG Matsabisa – Programme Director & Research• Ms J Petersen - PA and Office administrator• Mr Gustavo Luis Alfaro-Altuve – Business Develpmnt • Ms Neo Mooketsi MSc – Discovery Research• Mr D Ndiitwani MSc – Discovery Research• Ms MT Javu BA - THP and Community Liaison• Mr J Nyelimane - Technical support• Ms T Mbobo - Research support• Mr TK Lemena – Analytical chemistry• Mr M Ndumiso - Microbiology• Dr N Bapela – Pharmacology and Bioassays• Dr M Sekhoacha - Animal and Clinical Research• Dr D Molefe - Chemistry
Students & Interns:• Mr. P Legoale, PhD UWC• Ms A Rankoana, PhD, UL• Ms M Lekhooa, MSc intern FS• Mr B Sehume, MSc intern, UWC
Physicians and PIDr O Ebrahim – Brenthurst Clinic Dr E Yoosuf – Brenthurst Clinic Dr MA Dhansay – MRC Dr MD Khumalo – GP Botshabelo Prof A Dhai – Wits Prof A Walubo – UOVSDr M Mhlakaza – Centre for DiabetesDr P Moodley - GP
Project Leaders and collaborators
Dr Y Seier – Primate Unit MRC Dr M Mdhluli – Primate Unit (Operations) MRC Dr M Faber – Nutrition Intervention Unit MRC Dr M Smuts - Nutrition Intervention Unit ( NWU)
![Page 22: Medical Research Council - WIPO · Prof A Walubo – UOVS. Dr M Mhlakaza – Centre for Diabetes. Dr P Moodley - GP. Project Leaders and collaborators. Dr Y Seier – Primate Unit](https://reader034.vdocuments.us/reader034/viewer/2022042710/5f6a5c2009d50b07960c83c7/html5/thumbnails/22.jpg)
22
THANK YOU
We acknowledge support from:
Department of Science and Technology (NIKSO) – South Africa
Department of Health – South Africa
Medical Research Council of South Africa (MRC)
Our Communities, Knowledge Holders, TMK holders and Traditional Health Practitioners
Department of Social Development (Western Cape) – South Africa
SAASTA
NRF
WIPO and FICCI